WAmgen collaboration; BeiGene has China commercial rights. }Ensem collaboration; BeiGene has global rights. TDualityBio collaboration; BeiGene has global clinical, manufacturing, and commercialization rights. (Leads Biolabs collaboration; BeiGene has global research, development, and manufacturing rights, and exclusive commercialization rights outside of China. uZymeworks/Jazz collaboration; BeiGene has exclusive development and commercialization rights in Asia (except Japan), Australia, and New Zealand. ^Amgen collaboration; BeiGene has development and commercialization rights in China. YIn combination with Zanubrutinib. TMay include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor.
Welcome to BeOne
Medical Affairs
BeOne Medical Affairs is intended for health care professionals in the United States for the purpose of scientific exchange. This site contains educational resources and information relating to BeOne medicines, therapeutic areas of interest, congress materials, and publications. This site may include information on products or indications under investigation that are currently not approved in the United States. BeOne does not recommend the use of its products other than as described in the approved prescribing information. This site does not contain medical advice and does not replace independent medical judgment.
Please visit beonemedicines.us for more information.